• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchKiora Pharmaceuticals
    Picture of Kiora Pharmaceuticals logo

    KPRX — Kiora Pharmaceuticals News Story

    $2.290.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    • Market Cap
      $10.13m
    • Enterprise Value
      -$6.71m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • KPRX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    KPRX Dividends
    All News

    NASDAQ RESUMED AT 10:11 AM

    Picture of Kiora Pharmaceuticals logoKiora Pharmaceuticals
    12/08/2020 15:11
    NASDAQ RESUMED  EYEG.O  AT 10:11 AM
    

    Recent news on Kiora Pharmaceuticals

    See all news
    • Kiora Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary

      07/08/2026 12:34
    • Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview

      04/08/2026 13:57
    • Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing

      07/04/2026 12:29
    • Kiora Pharmaceuticals posts 2025 net loss as expenses rise

      25/03/2026 11:10
    • Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing

      15/09/2025 23:04

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.